Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.125NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
G.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
G.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
G.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
G.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.438ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.438ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.438ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.438NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.178ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.178ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.178ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.178NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.208ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.208ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.208ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.208NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.197ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.197ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.197ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.197NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.491ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.491ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.491ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.491NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.1.8 (Gamma)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.1.8 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.8 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.8 (Gamma)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.39.3 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.39.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
AY.39.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.39.3 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.75.3 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used